CrkL is a Co-Activator of Estrogen Receptor α That Enhances Tumorigenic Potential in Cancer

Renjini Ambika Padmanabhan(Rajiv Gandhi Centre for Biotechnology), Malini Laloraya(Rajiv Gandhi Centre for Biotechnology), Megha Murali(Rajiv Gandhi Centre for Biotechnology), Lini Nirmala(Rajiv Gandhi Centre for Biotechnology)
Molecular Endocrinology
June 24, 2011
Cited by 14


Related Papers